Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Strides Pharma Science Limited

http://www.strides.com/

Latest From Strides Pharma Science Limited

Aspen Faces Vaccine Setback In South Africa As Strides Explores Oral COVID Treatment

After a production setback, Aspen and Johnson & Johnson announce a donation of 300,000 vaccines to South African teachers. Strides partners with Ennaid for an oral COVID drug, while Dr Reddy’s, Lupin, Cipla and Sun Pharma Partner with Eli Lilly for baricitinib in India and Formycon receives approval for early action for its COVID-19 drug.

Coronavirus COVID-19 Approvals

Coronavirus Update: Brazil Opens Up Vaccine Imports

Brazil is permitting imports of additional coronavirus vaccines, while in India, Serum Institute will manufacture Sputnik V, the government is unifying vaccine sourcing, and emergency use approval has been granted to Lilly's anti-COVID-19 antibodies. 

Commercial Policy

Strides Considers Sputnik Light Production

Strides will consider making RDIF’s Sputnik Light vaccine after filling orders for Sputnik V, which it expects to launch in October. The COVID-19 portfolio is being expanded and the Indian company is set to make a Para IV filing for a diabetes product in December, CEO R Ananthanarayanan tells Scrip.

Commercial Coronavirus COVID-19

Strides’ Stelis Makes Progress With Its Biosimilar Pipeline

Strides’ Stelis is taking its next steps in the biosimilars segment with teriparatide, insulin glargine and insulin aspart. After recently completing Series B and Series C funding rounds worth $195m, Stelis also said that it was onboarding customers for its CDMO services under multi-year contracts. The company has also signed its first vaccine supply contract with the Russian Direct Investment Fund for the Sputnik V vaccine.

Biosimilars Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Strides Arcolab Ltd.
    • Strides Arcolab Limited
    • Amneal Pharmaceuticals Pty Limited, Australia
    • Faglis Medica Private Limited
    • Strides Shasun Limited
UsernamePublicRestriction

Register